(Q41671750)

English

Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

scientific article published on March 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis (English)

1 reference

Europe PubMed Central

6 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Palabrica TM

1

1 reference

Europe PubMed Central

6 October 2017

Liu AC

2

1 reference

Europe PubMed Central

6 October 2017

Aronovitz MJ

3

1 reference

Europe PubMed Central

6 October 2017

Furie B

4

1 reference

Europe PubMed Central

6 October 2017

Lawn RM

5

1 reference

Europe PubMed Central

6 October 2017

Furie BC

6

1 reference

Europe PubMed Central

6 October 2017

language of work or name

0 references

publication date

1 March 1995

1 reference

Europe PubMed Central

6 October 2017

Nature Medicine

1 reference

Europe PubMed Central

6 October 2017

1

1 reference

Europe PubMed Central

6 October 2017

256-259

1 reference

Europe PubMed Central

6 October 2017

3

1 reference

Europe PubMed Central

6 October 2017

https://scigraph.springernature.com/pub.10.1038/nm0395-256

0 references

Lipoprotein(a) and Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

21 January 2018

The mysteries of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein (a). Heterogeneity and biological relevance

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a), fibrin binding, and plasminogen activation.

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Does Lp(a) lipoprotein inhibit the fibrinolytic system?

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity of a monoclonal antibody for the NH2-terminal region of fibrin

1 reference

https://api.crossref.org/works/10.1038%2FNM0395-256

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NM0395-256

1 reference

Europe PubMed Central

6 October 2017

1 reference

Europe PubMed Central

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41671750&oldid=1925701225"